Literature DB >> 32508416

Study on the effect of an ion channel inhibitor "Fluralaner" on Echinococcus granulosus protoscolices and metacestode layers in vitro.

Fatima Zahran1, Hayam Mohamed Ezz El-Din1, Mai Abdel Sameaa Shehata1.   

Abstract

Hydatid disease has a great impact on public health, causing high morbidity and mortality. Main lines of treatment include surgery, which mostly requires the installation of a scolicidal agent into hydatid cysts to prevent dissemination. Alternatively, medical treatment involves the use of benzimidazole drugs; however, the results are not satisfactory, and new drug compounds are urgently needed. Fluralaner is a potent inhibitor of GABA-gated chloride channels and L-glutamate-gated chloride channels (GluCls) providing immediate and persistent flea, tick and mite control in dogs after a single oral dose. Researches previously identified different genes encoding ion channels in Echinococcus granulosus, making ion channel inhibitors a promising target for treating hydatid disease. Thus, the present study aimed to evaluate the effect of fluralaner on protoscolices and metacestode layers. Parasite materials (Protoscolices, Metacestodes layers) were exposed to different concentrations of the drug ranging from "12.5-100 ug/ml" and examined for viability after 1, 6 and 24 h. Morphological and ultrastructural alterations were recorded by both light and electron microscopies. Immunohistochemical staining confirmed caspase-3 activation as an indicator of apoptosis- induced therapy. The treated protoscolices and metacestode layers showed loss of the viability, the formation of vacuoles and lipid droplets, separation of the germinal layer, and damage in the laminated layer; apoptosis was prominent after treatment. These findings revealed that fluralaner has a potent scolicidal activity and suggested its therapeutic potential against hydatid disease. Further evaluations for animals and human use in the treatment and prevention of hydatid disease are needed. © Indian Society for Parasitology 2020.

Entities:  

Keywords:  Caspase 3; Echinococcus; Fluralaner; Hydatid disease; Ion channel; T.E.M.

Year:  2020        PMID: 32508416      PMCID: PMC7244642          DOI: 10.1007/s12639-020-01224-6

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  32 in total

1.  One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction.

Authors:  J E Richmond; E M Jorgensen
Journal:  Nat Neurosci       Date:  1999-09       Impact factor: 24.884

2.  The genome of the hydatid tapeworm Echinococcus granulosus.

Authors:  Huajun Zheng; Wenbao Zhang; Liang Zhang; Zhuangzhi Zhang; Jun Li; Gang Lu; Yongqiang Zhu; Yuezhu Wang; Yin Huang; Jing Liu; Hui Kang; Jie Chen; Lijun Wang; Aojun Chen; Shuting Yu; Zhengchao Gao; Lei Jin; Wenyi Gu; Zhiqin Wang; Li Zhao; Baoxin Shi; Hao Wen; Renyong Lin; Malcolm K Jones; Brona Brejova; Tomas Vinar; Guoping Zhao; Donald P McManus; Zhu Chen; Yan Zhou; Shengyue Wang
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

3.  Ivermectin used in percutaneous drug injection method for the treatment of liver hydatid disease in sheep.

Authors:  Murat Hokelek; Bekir Ahmet Deger; Emin Deger; Ediz Tutar; Mustafa Sunbul
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs.

Authors:  Feli M Walther; Mark J Allan; Rainer K A Roepke
Journal:  Parasit Vectors       Date:  2015-10-06       Impact factor: 3.876

Review 5.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

6.  Efficacy of thymol against Echinococcus granulosus protoscoleces.

Authors:  M Celina Elissondo; Clara M Albani; Liesel Gende; Martín Eguaras; Guillermo Denegri
Journal:  Parasitol Int       Date:  2007-12-23       Impact factor: 2.230

7.  Safety of fluralaner chewable tablets (Bravecto), a novel systemic antiparasitic drug, in dogs after oral administration.

Authors:  Feli M Walther; Mark J Allan; Rainer K A Roepke; Martin C Nuernberger
Journal:  Parasit Vectors       Date:  2014-03-07       Impact factor: 3.876

8.  Echinococcus granulosus genomics: a new dawn for improved diagnosis, treatment, and control of echinococcosis.

Authors:  Wenbao Zhang; Shengyue Wang; Donald P McManus
Journal:  Parasite       Date:  2014-12-17       Impact factor: 3.000

9.  Epidemiology and Clinical Features of Hydatid Cyst in Northern Iran from 2005 to 2015.

Authors:  Parisa Islami Parkoohi; Marjan Jahani; Fatemeh Hosseinzadeh; Shokufeh Taghian; Forugh Rostami; Abdollah Mousavi; Mohammad Sadegh Rezai
Journal:  Iran J Parasitol       Date:  2018 Apr-Jun       Impact factor: 1.012

10.  A single oral dose of fluralaner (Bravecto®) in dogs rapidly kills 100% of blood-fed Phlebotomus perniciosus, a main visceral leishmaniasis vector, for at least 1 month after treatment.

Authors:  G Bongiorno; L Meyer; A Evans; N Lekouch; R Bianchi; C Khoury; R Chiummo; E Thomas; L Gradoni
Journal:  Med Vet Entomol       Date:  2019-11-26       Impact factor: 2.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.